CFDE Data Portal | Search ZNF273

	Label	Description
	ZNF273 Gene (Entity type)	ENSG00000198039 - zinc finger protein 273
	ZNF273 associations Collection (Entity type)	Associations for ZNF273_associations
	ZNF273 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE168473 0 V 1 ISONIAZID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE226525 GSE226527 HNRNPH2 knockout 6 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE146358 dopamine 3 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE206927 PPARG knockdown endothelial cell 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 8 V 1 AZACITIDINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE192771 2 V 3 SORAFENIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

ZNF273

ENSG00000198039 - zinc finger protein 273

ZNF273 associations

Associations for ZNF273_associations

ZNF273 associations.tsv

A file from IDG as part of the Harmonizome project

GSE168473 0 V 1 ISONIAZID HUMAN UP

A Gene Set from LINCS

GSE226525 GSE226527 HNRNPH2 knockout 6 v 5 human up

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up

A Gene Set from LINCS

GSE146358 dopamine 3 v 7 human dn

A Gene Set from LINCS

GSE206927 PPARG knockdown endothelial cell 2 v 0 human up

A Gene Set from LINCS

GSE176008 8 V 1 AZACITIDINE HUMAN DN

A Gene Set from LINCS

GSE192771 2 V 3 SORAFENIB HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.